Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Person › Details

Arthur Lahr (Kiadis Pharma N.V. (Euronext: KDS))

Lahr, Arthur (Kiadis 201704– CEO before Crucell 200701 Chief Strategy Officer + EP Sales + BusDev)


Organisations Organisation Kiadis Pharma N.V. (Euronext: KDS)
  Group Kiadis (Group)
  Former/major organisation Crucell N.V. (Euronext: CRXL, Nasdaq: CRXL)
  Group Johnson & Johnson (JnJ) (Group)
Product Product ATIR™ (Kiadis)
Document Source Kiadis Pharma N.V.. (6/13/17). "Press Release: Kiadis Pharma Raises €5 Million in Private Placement with Institutional Investors [Not for US, AU, CA, JP, ZA or any other jurisdiction where unlawful]". Amsterdam.

Record changed: 2020-11-02


Picture [iito] Made Without Love 650x80px

More documents for Arthur Lahr

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC E Hand 650x300px

» top